drugset / Trial / NCT04763070

Ciprofloxacin in Drug-resistant Epilepsy

NCT04763070

NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the effect of a short-term prescription of ciprofloxacin on intestinal microbial pattern and seizure frequency of patients with drug-resistant epilepsy.

Timeline

Start
2020-10-01
Primary completion
2021-04-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 500 mg Oral

Indications